PharmaShots Weekly Snapshots (August 02 - 06, 2021)
Medtronic to Acquire Intersect ENT for ~$1.1B
Published: Aug 6, 2021 | Tags: Medtronic, Intersect ENT, ~$1.1B
Published: Aug 6, 2021 | Tags: Kite, Appia, Allogeneic Cell Therapies, Cancer
Polpharma & Bioeq Report BLA Submission to the US FDA for FYB201 (biosimilar, ranibizumab)
Published: Aug 6, 2021 | Tags: Polpharma, Bioeq, BLA, FDA, FYB201, biosimilar, ranibizumab
Published: Aug 6, 2021 | Tags: Takeda, Takhzyro, lanadelumab, P-III, HELP OLE Study, Hereditary Angioedema Attacks, Allergy
AstraZeneca Signs an Exclusive License Agreement with Sierra for AZD5153 to Treat Myelofibrosis
Published: Aug 6, 2021 | Tags: Sierra, AstraZeneca, AZD5153, Myelofibrosis
Bayer to Acquire Vividion for ~$2B
Published: Aug 6, 2021 | Tags: Bayer, Vividion, Drug Discovery Platform, ~$2B
Published: Aug 5, 2021 | Tags: Merck, Keytruda, pembrolizumab, P-III, KEYNOTE-716 Trial, Stage II, Resected High-Risk Melanoma
Published: Aug 5, 2021 | Tags: Regeneron, Sanofi, P-III, EMPOWER-Lung 3 Trial, Libtayo, Platinum-Doublet CT, NSCLC
Published: Aug 5, 2021 | Tags: Regeneron, REGEN-COV, casirivimab, imdevimab, P-III, Trial, COVID 19, NEJM
Pfizer Reports Results of Ritlecitinib in P-IIb/III Trial for the Treatment of Alopecia Areata
Published: Aug 5, 2021 | Tags: Pfizer, Ritlecitinib, P-IIb/III, Trial, Alopecia Areata
Published: Aug 5, 2021 | Tags: Schrödinger, Zai Lab, Oncology program, DNA damage response
F-star Collaborates with MSD to Evaluate FS120 + Keytruda for the Treatment of Cancer
Published: Aug 5, 2021 | Tags: F-star, MSD, FS120, Keytruda, Cancer
Published: Aug 4, 2021 | Tags: BeyondSpring, Plinabulin, Docetaxel, P-III, DUBLIN-3 Trial, NSCLC, EGFR Wild Type
Published: Aug 4, 2021 | Tags: Outlook, ONS-5010, Lytenava, bevacizumab-vikg, P-III, NORSE TWO Trial, Wet AMD
Celltrion to Supply Herzuma (biosimilar, trastuzumab) and Truxima (biosimilar, rituximab) in Brazil
Published: Aug 4, 2021 | Tags: Celltrion, Herzuma, biosimilar, trastuzumab, Truxima, rituximab, Brazil
Published: Aug 4, 2021 | Tags: Tachyon, AbCellera, Novel Antibody Therapeutic, TGF-ß Superfamily Member, Cancer
Published: Aug 4, 2021 | Tags: Bayer, Eliapixant, BAY1817080, P-IIb, Study, Refractory Chronic Cough
Marinus Signs an Agreement with Orion for the Commercialization of Ganaxolone in EU
Published: Aug 4, 2021 | Tags: Marinus, Orion, Ganaxolone, EU
Published: Aug 3, 2021 | Tags: Lilly, Incyte, Baricitinib, P-III, COV-BARRIER Study, COVID 19
Published: Aug 3, 2021 | Tags: UCB, Bimekizumab, NICE Recommendation, Severe Plaque Psoriasis
Novartis Lifts Partial Clinical Trial Hold on OAV-101 Clinical Program to Treat SMA
Published: Aug 3, 2021 | Tags: Novartis, Partial, Clinical Trial Hold, OAV-101, SMA
Published: Aug 3, 2021 | Tags: Roche, US, FDA, BLA, Priority Review, Tecentriq, atezolizumab, NSCLC
Sanofi to Acquire Translate Bio for ~$3.2B
Published: Aug 3, 2021 | Tags: Sanofi, Translate Bio, ~$3.2B
Abbott Launches Jot Dx Insertable Cardiac Monitor to Detect Abnormal Heart Rhythms in US
Published: Aug 3, 2021 | Tags: Abbott, Jot Dx, Insertable Cardiac Monitor, Abnormal Heart Rhythms, US
Regeneron Reports the EUA Expansion for REGEN-COV (casirivimab and imdevimab) to Treat COVID 19
Published: Aug 2, 2021 | Tags: Regeneron, EUA, REGEN-COV, casirivimab, imdevimab, COVID 19
Published: Aug 2, 2021 | Tags: Ipsen, Exicure, SNA-Based Therapeutics, Rare Neurodegenerative Disorders
Published: Aug 2, 2021 | Tags: Janssen, UPTRAVI, selexipag, US, FDA, Approval, Pulmonary Arterial Hypertension
Published: Aug 2, 2021 | Tags: AstraZeneca, Saphnelo, anifrolumab-fnia, US, FDA, Approval, Systemic Lupus Erythematosus
Published: Aug 2, 2021 | Tags: Takeda, Frazier, HilleVax, biopharma company, HIL-214
Astellas Signs a License Agreement with Minovia for Novel Mitochondrial Cell Therapy Programs
Published: Aug 2, 2021 | Tags: Astellas, Minovia, Mitochondrial Cell Therapy Programs
Related Post: PharmaShots Weekly Snapshots (July 26 - 30, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com